Fast-fashion giant Shein is facing significant hurdles in its pursuit of a Hong Kong stock exchange listing, with profitability concerns casting a long shadow over its ambitions. The company, which built its
2026 has proven to be a pivotal but complicated year for workplace artificial intelligence regulation, with new state laws taking effect while federal efforts to preempt them move slowly. Several new state
More
Morgan Lewis has introduced a dedicated coaching program designed to help lawyer-parents navigate the transition back to work after parental leave. The initiative offers mentorship, practical resources, and support focused on work-life
More
Investec Group (LSE: INVP) is emerging as one of the more compelling dividend stories on the FTSE 100 for ISA investors seeking tax-efficient income growth. A Stocks and Shares ISA remains one
More
Granite Ridge Resources (GRNT) and its peers across the energy sector are drawing renewed investor attention as oil price volatility continues to reshape market sentiment. Crude oil prices have faced significant pressure
More
The U.S. Food and Drug Administration has issued an untitled letter to Alar Pharmaceuticals over misleading promotional claims about an investigational ketamine treatment. The FDA’s Office of Prescription Drug Promotion issued the
More
The Fifth Circuit has delivered a major victory for healthcare providers by striking down the government’s methodology for calculating qualifying payment amounts under the No Surprises Act. The court’s en banc decision,
More
In 1858, an Illinois trial lawyer defended a young man charged with murder and used a simple almanac to dismantle the prosecution’s entire case. The government’s star witness claimed he had watched
More
Butterfield Bank, trading under the ticker NTB, continues to attract investor attention as analysts suggest the stock still trades at a notable discount to fair value. The Bermuda-based lender has delivered a
More
The FTSE 250 index remains a closely watched benchmark for investors seeking exposure to mid-cap British companies with strong domestic and international growth potential. Artificial intelligence tools such as ChatGPT have grown
More
AstraZeneca (AZN) appears to be stepping back from combination therapy approaches in transthyretin amyloid cardiomyopathy following a significant phase 3 clinical failure. The setback involved Wainua, a drug developed in partnership with
More